Anteneh Tesfaye is an Oncology physician affiliated with Georgetown University. OpenAlex indexes 113 publications with 1,012 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 Irving St NW Ste C2151
Washington, DC 200103017
Telephone
202-877-6998Provider last certified this registry record 19 Nov 2021.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year202412 payments
- Novartis Pharmaceuticals CorporationProgram year20244 payments
- Merck Sharp & Dohme LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38%Kinase inhibitor31%Lenvima43%Everolimus36%Cabometyx21%Part D<11 patientsNucleoside Analog Antiviral7%Lonsurf100%Part D<11 patientsNervous system
18.7%Phenothiazine7%Prochlorperazine Maleate100%Part D<11 patientsTricyclic Antidepressant5.9%Amitriptyline Hcl100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
11.8%Serotonin-3 Receptor Antagonist11.8%Ondansetron Odt100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-world microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) in pancreatic adenocarcinoma (PDAC).
Journal of Clinical Oncology
2025 - ABS0164 TAILORED SYNOVIAL FLUID ISOLATION PROTOCOL FOR A COMPREHENSIVE CELLULAR PROFILING IN INFLAMMATORY ARTHRITIS
Annals of the Rheumatic Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Augusto Pichard, MD
Georgetown University
Virginia Steen
Georgetown University
Joseph Verbalis
Georgetown University
Craig Kessler
Georgetown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”